Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapyJennifer E. Adair(University of Massachusetts Chan Medical School), Hans‐Peter Kiem(Fred Hutch Cancer Center)Nature CommunicationsOctober 20, 201610.1038/ncomms13173Cited by 43SaveCiteExport RISWatch citationsRelated PapersHematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects|Blood|2001|1.4kTowards access for all: 1st Working Group Report for the Global Gene Therapy Initiative (GGTI)|Gene Therapy|2021|39